Stocks Health care TNXP
NASDAQ · Health careTonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. brought in $29.1M of revenue over the twelve months to June 30, 2026, up 196.0% from a year earlier. It posted a net loss of $159.7M. In fiscal 2025 capital spending exceeded operating cash flow by $103.2M. At June 30, 2026 it held $176.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Tonix Pharmaceuticals Holding Corp. does
Tonix Pharmaceuticals Holding Corp. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TNXP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $13.1M | -$124M | -$14.57 | -$103.2M |
| 2024 | $10.1M | -$130M | -$176.60 | -$61M |
| 2023 | $7.8M | -$116.7M | -$14,720.25 | -$109.9M |
| 2022 | n/a | -$110.2M | -$43,000.32 | -$146.2M |
| 2021 | n/a | -$92.3M | -$106,514.56 | -$110.9M |
| 2020 | n/a | -$50.5M | -$225,319.26 | -$57.1M |
Latest SEC filings
What Tonix Pharmaceuticals Holding Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026Other event 8-K
- September 8, 2026Other event 8-K
- August 18, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- August 3, 2026
- July 21, 2026
- July 13, 2026
Questions about TNXP
What does Tonix Pharmaceuticals Holding Corp. do?
Tonix Pharmaceuticals Holding Corp. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TNXP.
Is Tonix Pharmaceuticals Holding Corp. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $159.7M on revenue of $29.1M.
How much revenue does Tonix Pharmaceuticals Holding Corp. make?
Over the twelve months to June 30, 2026 Tonix Pharmaceuticals Holding Corp. reported revenue of $29.1M. That is 196.0% more than a year earlier.
When did Tonix Pharmaceuticals Holding Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 22, 2026.
Similar companies
Follow TNXP
Get an email when Tonix Pharmaceuticals Holding Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Follow TNXP: get an email when it filesWhere the numbers come from
Financial figures are the values Tonix Pharmaceuticals Holding Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.